Cargando…

Purifying Selection in Human Immunodeficiency Virus-1 pol Gene in Perinatally Human Immunodeficiency Virus-1-Infected Children Harboring Discordant Immunological Response and Virological Nonresponse to Long-Term Antiretroviral Therapy

BACKGROUND: Biological monitoring of antiretroviral treatment (ART) in human immunodeficiency virus (HIV)-infected pediatric population remains challenging. The aim of the present study was to assess the long-term HIV-1 genetic diversity in pol gene in HIV-1-infected children in virological failure...

Descripción completa

Detalles Bibliográficos
Autores principales: Mboumba Bouassa, Ralph-Sydney, Pere, Helene, Mossoro-Kpinde, Christian Diamant, Roques, Pierre, Gody, Jean Chrysostome, Moussa, Sandrine, Veyer, David, Gresenguet, Gerard, Charpentier, Charlotte, Jenabian, Mohammad-Ali, Djoba Siawaya, Joel Fleury, Belec, Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295550/
https://www.ncbi.nlm.nih.gov/pubmed/32587653
http://dx.doi.org/10.14740/jocmr4157
_version_ 1783546671497478144
author Mboumba Bouassa, Ralph-Sydney
Pere, Helene
Mossoro-Kpinde, Christian Diamant
Roques, Pierre
Gody, Jean Chrysostome
Moussa, Sandrine
Veyer, David
Gresenguet, Gerard
Charpentier, Charlotte
Jenabian, Mohammad-Ali
Djoba Siawaya, Joel Fleury
Belec, Laurent
author_facet Mboumba Bouassa, Ralph-Sydney
Pere, Helene
Mossoro-Kpinde, Christian Diamant
Roques, Pierre
Gody, Jean Chrysostome
Moussa, Sandrine
Veyer, David
Gresenguet, Gerard
Charpentier, Charlotte
Jenabian, Mohammad-Ali
Djoba Siawaya, Joel Fleury
Belec, Laurent
author_sort Mboumba Bouassa, Ralph-Sydney
collection PubMed
description BACKGROUND: Biological monitoring of antiretroviral treatment (ART) in human immunodeficiency virus (HIV)-infected pediatric population remains challenging. The aim of the present study was to assess the long-term HIV-1 genetic diversity in pol gene in HIV-1-infected children in virological failure under antiretroviral regimen adapted according to the successive World Health Organization (WHO) guidelines for resource-constrained settings. METHODS: HIV-1 diversity in pol gene was assessed in HIV-1-infected children and adolescents born from HIV-infected mothers (median age at follow-up: 13.8 years) in virological failure (VF(+)) despite long-term regimen recommended by the WHO. The numbers of nonsynonymous substitutions per potential nonsynonymous site (dN) and of synonymous substitutions at potential synonymous sites (dS) in HIV-1 pol gene and the dN/dS ratios were used to estimate the selective pressure on circulating HIV-1. RESULTS: The immunological responses to ART basically corresponded to: 1) Full therapeutic failure with immunological (I(-)) and virological nonresponses in one-quarter (24.6%) of study children ((I(-), VF(+)) subgroup); 2) Discordant immunovirological responses with paradoxical high CD4 T cell counts (I(+)) and high HIV-1 RNA load in the remaining cohort patients (75.4%) ((I(+), VF(+)) subgroup). The mean dS was 1.8-fold higher in (I(+), VF(+)) than (I(-), VF(+)) subgroup (25.9 ± 18.4 vs. 14.3 ± 10.8). In the (I(+), VF(+)) subgroup, the mean dS was 1.6-fold higher than the mean dN. Finally, the mean dN/dS ratio was 2.1-fold lower in (I(+), VF(+)) than (I(-), VF(+)) subgroup (0.6 ± 0.3 vs. 1.3 ± 0.7), indicating purifying selection in the immunovirological discordant (I(+), VF(+)) subgroup and positive selection in the immunovirological failure (I(-), VF(+)) subgroup. CONCLUSIONS: Children and adolescents in immunovirological therapeutic failure harbor positive selection of HIV-1 strains favoring diversifying in pol-encoded amino acids. In contrast, children with persistent discordant immunovirological responses show accumulation of mutations and purifying selection in pol gene sequences, indicating limited genetic evolution and likely suggesting genetic adaptation of viruses to host functional constraints.
format Online
Article
Text
id pubmed-7295550
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elmer Press
record_format MEDLINE/PubMed
spelling pubmed-72955502020-06-24 Purifying Selection in Human Immunodeficiency Virus-1 pol Gene in Perinatally Human Immunodeficiency Virus-1-Infected Children Harboring Discordant Immunological Response and Virological Nonresponse to Long-Term Antiretroviral Therapy Mboumba Bouassa, Ralph-Sydney Pere, Helene Mossoro-Kpinde, Christian Diamant Roques, Pierre Gody, Jean Chrysostome Moussa, Sandrine Veyer, David Gresenguet, Gerard Charpentier, Charlotte Jenabian, Mohammad-Ali Djoba Siawaya, Joel Fleury Belec, Laurent J Clin Med Res Original Article BACKGROUND: Biological monitoring of antiretroviral treatment (ART) in human immunodeficiency virus (HIV)-infected pediatric population remains challenging. The aim of the present study was to assess the long-term HIV-1 genetic diversity in pol gene in HIV-1-infected children in virological failure under antiretroviral regimen adapted according to the successive World Health Organization (WHO) guidelines for resource-constrained settings. METHODS: HIV-1 diversity in pol gene was assessed in HIV-1-infected children and adolescents born from HIV-infected mothers (median age at follow-up: 13.8 years) in virological failure (VF(+)) despite long-term regimen recommended by the WHO. The numbers of nonsynonymous substitutions per potential nonsynonymous site (dN) and of synonymous substitutions at potential synonymous sites (dS) in HIV-1 pol gene and the dN/dS ratios were used to estimate the selective pressure on circulating HIV-1. RESULTS: The immunological responses to ART basically corresponded to: 1) Full therapeutic failure with immunological (I(-)) and virological nonresponses in one-quarter (24.6%) of study children ((I(-), VF(+)) subgroup); 2) Discordant immunovirological responses with paradoxical high CD4 T cell counts (I(+)) and high HIV-1 RNA load in the remaining cohort patients (75.4%) ((I(+), VF(+)) subgroup). The mean dS was 1.8-fold higher in (I(+), VF(+)) than (I(-), VF(+)) subgroup (25.9 ± 18.4 vs. 14.3 ± 10.8). In the (I(+), VF(+)) subgroup, the mean dS was 1.6-fold higher than the mean dN. Finally, the mean dN/dS ratio was 2.1-fold lower in (I(+), VF(+)) than (I(-), VF(+)) subgroup (0.6 ± 0.3 vs. 1.3 ± 0.7), indicating purifying selection in the immunovirological discordant (I(+), VF(+)) subgroup and positive selection in the immunovirological failure (I(-), VF(+)) subgroup. CONCLUSIONS: Children and adolescents in immunovirological therapeutic failure harbor positive selection of HIV-1 strains favoring diversifying in pol-encoded amino acids. In contrast, children with persistent discordant immunovirological responses show accumulation of mutations and purifying selection in pol gene sequences, indicating limited genetic evolution and likely suggesting genetic adaptation of viruses to host functional constraints. Elmer Press 2020-06 2020-06-04 /pmc/articles/PMC7295550/ /pubmed/32587653 http://dx.doi.org/10.14740/jocmr4157 Text en Copyright 2020, Mboumba Bouassa et al. http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Mboumba Bouassa, Ralph-Sydney
Pere, Helene
Mossoro-Kpinde, Christian Diamant
Roques, Pierre
Gody, Jean Chrysostome
Moussa, Sandrine
Veyer, David
Gresenguet, Gerard
Charpentier, Charlotte
Jenabian, Mohammad-Ali
Djoba Siawaya, Joel Fleury
Belec, Laurent
Purifying Selection in Human Immunodeficiency Virus-1 pol Gene in Perinatally Human Immunodeficiency Virus-1-Infected Children Harboring Discordant Immunological Response and Virological Nonresponse to Long-Term Antiretroviral Therapy
title Purifying Selection in Human Immunodeficiency Virus-1 pol Gene in Perinatally Human Immunodeficiency Virus-1-Infected Children Harboring Discordant Immunological Response and Virological Nonresponse to Long-Term Antiretroviral Therapy
title_full Purifying Selection in Human Immunodeficiency Virus-1 pol Gene in Perinatally Human Immunodeficiency Virus-1-Infected Children Harboring Discordant Immunological Response and Virological Nonresponse to Long-Term Antiretroviral Therapy
title_fullStr Purifying Selection in Human Immunodeficiency Virus-1 pol Gene in Perinatally Human Immunodeficiency Virus-1-Infected Children Harboring Discordant Immunological Response and Virological Nonresponse to Long-Term Antiretroviral Therapy
title_full_unstemmed Purifying Selection in Human Immunodeficiency Virus-1 pol Gene in Perinatally Human Immunodeficiency Virus-1-Infected Children Harboring Discordant Immunological Response and Virological Nonresponse to Long-Term Antiretroviral Therapy
title_short Purifying Selection in Human Immunodeficiency Virus-1 pol Gene in Perinatally Human Immunodeficiency Virus-1-Infected Children Harboring Discordant Immunological Response and Virological Nonresponse to Long-Term Antiretroviral Therapy
title_sort purifying selection in human immunodeficiency virus-1 pol gene in perinatally human immunodeficiency virus-1-infected children harboring discordant immunological response and virological nonresponse to long-term antiretroviral therapy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295550/
https://www.ncbi.nlm.nih.gov/pubmed/32587653
http://dx.doi.org/10.14740/jocmr4157
work_keys_str_mv AT mboumbabouassaralphsydney purifyingselectioninhumanimmunodeficiencyvirus1polgeneinperinatallyhumanimmunodeficiencyvirus1infectedchildrenharboringdiscordantimmunologicalresponseandvirologicalnonresponsetolongtermantiretroviraltherapy
AT perehelene purifyingselectioninhumanimmunodeficiencyvirus1polgeneinperinatallyhumanimmunodeficiencyvirus1infectedchildrenharboringdiscordantimmunologicalresponseandvirologicalnonresponsetolongtermantiretroviraltherapy
AT mossorokpindechristiandiamant purifyingselectioninhumanimmunodeficiencyvirus1polgeneinperinatallyhumanimmunodeficiencyvirus1infectedchildrenharboringdiscordantimmunologicalresponseandvirologicalnonresponsetolongtermantiretroviraltherapy
AT roquespierre purifyingselectioninhumanimmunodeficiencyvirus1polgeneinperinatallyhumanimmunodeficiencyvirus1infectedchildrenharboringdiscordantimmunologicalresponseandvirologicalnonresponsetolongtermantiretroviraltherapy
AT godyjeanchrysostome purifyingselectioninhumanimmunodeficiencyvirus1polgeneinperinatallyhumanimmunodeficiencyvirus1infectedchildrenharboringdiscordantimmunologicalresponseandvirologicalnonresponsetolongtermantiretroviraltherapy
AT moussasandrine purifyingselectioninhumanimmunodeficiencyvirus1polgeneinperinatallyhumanimmunodeficiencyvirus1infectedchildrenharboringdiscordantimmunologicalresponseandvirologicalnonresponsetolongtermantiretroviraltherapy
AT veyerdavid purifyingselectioninhumanimmunodeficiencyvirus1polgeneinperinatallyhumanimmunodeficiencyvirus1infectedchildrenharboringdiscordantimmunologicalresponseandvirologicalnonresponsetolongtermantiretroviraltherapy
AT gresenguetgerard purifyingselectioninhumanimmunodeficiencyvirus1polgeneinperinatallyhumanimmunodeficiencyvirus1infectedchildrenharboringdiscordantimmunologicalresponseandvirologicalnonresponsetolongtermantiretroviraltherapy
AT charpentiercharlotte purifyingselectioninhumanimmunodeficiencyvirus1polgeneinperinatallyhumanimmunodeficiencyvirus1infectedchildrenharboringdiscordantimmunologicalresponseandvirologicalnonresponsetolongtermantiretroviraltherapy
AT jenabianmohammadali purifyingselectioninhumanimmunodeficiencyvirus1polgeneinperinatallyhumanimmunodeficiencyvirus1infectedchildrenharboringdiscordantimmunologicalresponseandvirologicalnonresponsetolongtermantiretroviraltherapy
AT djobasiawayajoelfleury purifyingselectioninhumanimmunodeficiencyvirus1polgeneinperinatallyhumanimmunodeficiencyvirus1infectedchildrenharboringdiscordantimmunologicalresponseandvirologicalnonresponsetolongtermantiretroviraltherapy
AT beleclaurent purifyingselectioninhumanimmunodeficiencyvirus1polgeneinperinatallyhumanimmunodeficiencyvirus1infectedchildrenharboringdiscordantimmunologicalresponseandvirologicalnonresponsetolongtermantiretroviraltherapy